These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2054256)

  • 1. A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF.
    Olsson I; Gullberg U; Lantz M; Peetre C
    Biotherapy; 1991; 3(2):159-65. PubMed ID: 2054256
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor (TNF alpha) binding protein: interference in immunoassays of TNF alpha.
    Haran N; Bar-Khayim Y; Frensdorff A; Barnard G
    Kidney Int; 1991 Dec; 40(6):1166-70. PubMed ID: 1762319
    [No Abstract]   [Full Text] [Related]  

  • 3. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.
    Lantz M; Thysell H; Nilsson E; Olsson I
    J Clin Invest; 1991 Dec; 88(6):2026-31. PubMed ID: 1752960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis.
    Ferrajoli A; Talpaz M; Kurzrock R; Estrov Z
    Stem Cells; 1993 Mar; 11(2):112-9. PubMed ID: 8384506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids.
    Adolf GR; Apfler I
    J Immunol Methods; 1991 Sep; 143(1):127-36. PubMed ID: 1919033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide.
    Töllner B; Roth J; Störr B; Martin D; Voigt K; Zeisberger E
    Pflugers Arch; 2000 Oct; 440(6):925-32. PubMed ID: 11041560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans.
    Lantz M; Malik S; Slevin ML; Olsson I
    Cytokine; 1990 Nov; 2(6):402-6. PubMed ID: 2129506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A secreted high-affinity inhibitor of human TNF from Tanapox virus.
    Brunetti CR; Paulose-Murphy M; Singh R; Qin J; Barrett JW; Tardivel A; Schneider P; Essani K; McFadden G
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4831-6. PubMed ID: 12676996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis.
    Cooney R; Iocono J; Maish G; Smith JS; Ehrlich P
    J Trauma; 1997 Mar; 42(3):415-20. PubMed ID: 9095108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model.
    Hingorani A; Ascher E; Scheinman M; Yorkovich W; DePippo P; Ladoulis CT; Salles-Cunha S
    J Vasc Surg; 1998 Sep; 28(3):522-6. PubMed ID: 9737463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a tumor necrosis factor binding protein from urine.
    Olsson I; Lantz M; Nilsson E; Peetre C; Thysell H; Grubb A; Adolf G
    Eur J Haematol; 1989 Mar; 42(3):270-5. PubMed ID: 2924890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SODD-silencer of death domains.
    Harrington JR
    Stem Cells; 2000; 18(5):388-9. PubMed ID: 11007926
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF.
    Moos AB; Baecher-Steppan L; Kerkvliet NI
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):331-5. PubMed ID: 8048078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.
    Sutton ET; Thomas T; Bryant MW; Landon CS; Newton CA; Rhodin JA
    J Submicrosc Cytol Pathol; 1999 Jul; 31(3):313-23. PubMed ID: 10626000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein.
    Ledgerwood EC; Prins JB; Bright NA; Johnson DR; Wolfreys K; Pober JS; O'Rahilly S; Bradley JR
    Biochem Soc Trans; 1998 Nov; 26(4):S316. PubMed ID: 10047830
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective release of tumor necrosis factor binding protein II by malignant human epidermal cells reveals protection from tumor necrosis factor alpha-mediated cytotoxicity.
    Neuner P; Klosner G; Pourmojib M; Trautinger F; Knobler R
    Cancer Res; 1994 Nov; 54(22):6001-5. PubMed ID: 7954434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.